LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 08, 2023
Source ID
10.1172/jci.insight.167440

Entities

People

  • Aaron Udager
  • Anbarasu Kumaraswamy
  • Archana Sehrawat
  • Armand Bankhead Iii
  • Arul Chinnaiyan
  • Arvind Rao
  • Chao Zhang
  • Colm Morrissey
  • Diana Flores
  • Eva Rodansky
  • Ilsa M. Coleman
  • Joel A Yates
  • John K Lee
  • Joshi J Alumkal
  • Joshua Agbemefa Kuleape
  • Karan Bedi
  • Olivia A. Swaim
  • Peter S Nelson
  • Rahul Mannan
  • Visweswaran Ravikumar
  • William K. Storck
  • Xiao-Ming Wang
  • Ya-Mei Hu
  • Zheng Xia
  • Zhi Duan

Organizations

  • National Cancer Institute
  • Prostate Cancer Foundation
  • United States Department of Defense